STEPHANIE SULLIVAN: Open Payments
NPI 1194160044 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,014 in 156 payments from 18 companies in 2025. Trend: 2023 $2,764 · 2024 $2,736 · 2025 $3,014
Food & beverage: $2,916Education: $98
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $695 |
| Regeneron Healthcare Solutions, Inc. | 14 | $408 |
| UCB, Inc. | 20 | $375 |
| Arcutis Biotherapeutics, Inc. | 14 | $250 |
| GENZYME CORPORATION | 11 | $242 |
| Galderma Laboratories, L.P. | 12 | $167 |
| Amgen Inc. | 10 | $151 |
| PFIZER INC. | 3 | $146 |
| Janssen Biotech, Inc. | 12 | $145 |
| Novartis Pharmaceuticals Corporation | 3 | $94 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, Zoryve, RINVOQ, OTEZLA, TREMFYA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
